List of bibliographic references
Number of relevant bibliographic references: 32.
[0-20] [
0 - 20][
0 - 32][
20-31][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000008 (2001) |
S. Braun [Allemagne] ; J. Ramaker ; E. Dippel ; C C Zouboulis | [Schonlein-Henoch purpura associated with hepatitis B in a patient with HIV infection]. |
| 000028 (2003) |
Anna Oevermann [Suisse] ; Monika Engels ; Ursula Thomas ; Antonio Pellegrini | The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification. |
| 000061 (2005) |
Jason Paragas [États-Unis] ; Lawrence M. Blatt ; Chris Hartmann ; John W. Huggins ; Tim P. Endy | Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models. |
| 000164 (2009) |
Yoon-Suk Lee [Corée du Sud] ; Sun Min Park ; Byeang Hyean Kim | Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. |
| 000223 (2010) |
Krishnan Suresh Kumar [Inde] ; Swastika Ganguly ; Ravichandran Veerasamy ; Erik De Clercq | Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones. |
| 000278 (2011) |
S K Krishnan [Inde] ; S. Ganguly ; R. Veerasamy ; B. Jan | Synthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones. |
| 000302 (2012) |
Anna-Winona Struck [Allemagne] ; Marco Axmann ; Susanne Pfefferle ; Christian Drosten ; Bernd Meyer | A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2. |
| 000323 (2012) |
Dirk Jochmans [Belgique] ; Pieter Leyssen ; Johan Neyts | A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. |
| 000376 (2013) |
Mi Kyoung Kim [Corée du Sud] ; Hyunjun Yoon ; Dale Lynn Barnard ; Youhoon Chong | Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives. |
| 000508 (2014) |
Mohammad Khalid ; Basha Khan ; Fahad Al Rabiah ; Ruwaida Alismaili ; Sarfraz Saleemi ; Agha Muhammad Rehan-Khaliq ; Ihab Weheba ; Hail Al Abdely ; Magid Halim ; Quaid Johar Nadri ; Abdullah Mohsin Al Dalaan ; Mohamed Zeitouni ; Taimur Butt ; Eid Al Mutairy | Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia |
| 000853 (2019) |
Ayman M S. Ahmed [Égypte] ; Reham A I. Abou-Elkhair [Égypte] ; Alaa M. El-Torky [Égypte] ; Abdalla E A. Hassan [Égypte] | 3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation. |
| 000875 (2019) |
Mohammed Albratty [Arabie saoudite] ; Karam Ahmed El-Sharkawy [Arabie saoudite] ; Hassan Ahmed Alhazmi [Arabie saoudite] | Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents. |
| 000924 (2020) |
Ewen Callaway ; David Cyranoski | China coronavirus: Six questions scientists are asking. |
| 000925 (2020) |
David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000928 (2020) |
Hongzhou Lu [République populaire de Chine] | Drug treatment options for the 2019-new coronavirus (2019-nCoV). |
| 000953 (2020) |
Fei Yu [République populaire de Chine] ; Lanying Du [États-Unis] ; David M. Ojcius [États-Unis] ; Chungen Pan [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] | Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. |
| 000957 (2020) |
Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro |
| 000962 (2020) |
Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis] | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. |
| 000968 (2020) |
Ying-Hui Jin [République populaire de Chine] ; Lin Cai [République populaire de Chine] ; Zhen-Shun Cheng [République populaire de Chine] ; Hong Cheng [République populaire de Chine] ; Tong Deng [République populaire de Chine] ; Yi-Pin Fan [République populaire de Chine] ; Cheng Fang [République populaire de Chine] ; Di Huang [République populaire de Chine] ; Lu-Qi Huang [République populaire de Chine] ; Qiao Huang [République populaire de Chine] ; Yong Han [République populaire de Chine] ; Bo Hu [République populaire de Chine] ; Fen Hu [République populaire de Chine] ; Bing-Hui Li [République populaire de Chine] ; Yi-Rong Li [République populaire de Chine] ; Ke Liang [République populaire de Chine] ; Li-Kai Lin [République populaire de Chine] ; Li-Sha Luo [République populaire de Chine] ; Jing Ma [République populaire de Chine] ; Lin-Lu Ma [République populaire de Chine] ; Zhi-Yong Peng [République populaire de Chine] ; Yun-Bao Pan [République populaire de Chine] ; Zhen-Yu Pan [République populaire de Chine] ; Xue-Qun Ren [République populaire de Chine] ; Hui-Min Sun [République populaire de Chine] ; Ying Wang [République populaire de Chine] ; Yun-Yun Wang [République populaire de Chine] ; Hong Weng [République populaire de Chine] ; Chao-Jie Wei [République populaire de Chine] ; Dong-Fang Wu [République populaire de Chine] ; Jian Xia [République populaire de Chine] ; Yong Xiong [République populaire de Chine] ; Hai-Bo Xu [République populaire de Chine] ; Xiao-Mei Yao [Canada] ; Yu-Feng Yuan [République populaire de Chine] ; Tai-Sheng Ye [République populaire de Chine] ; Xiao-Chun Zhang [République populaire de Chine] ; Ying-Wen Zhang [République populaire de Chine] ; Yin-Gao Zhang [République populaire de Chine] ; Hua-Min Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Ming-Juan Zhao [République populaire de Chine] ; Hao Zi [République populaire de Chine] ; Xian-Tao Zeng [République populaire de Chine] ; Yong-Yan Wang [République populaire de Chine] ; Xing-Huan Wang [République populaire de Chine] | A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). |
| 000973 (2020) |
Heshui Shi ; Xiaoyu Han ; Chuansheng Zheng | Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China. |
| 000980 (2020) |
Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine] | Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Antiviral Agents"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i \
-Sk "Antiviral Agents" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= Mesh.i
|clé= Antiviral Agents
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021 |  |
